福斯科林市场规模、份额、成长分析（按实力、按应用、按最终用户、按地区）—2025 年至 2032 年产业预测

2023 年，福斯可林市场规模价值为 5.113 亿美元，预计将从 2024 年的 5.6396 亿美元扩大到 2032 年的 12.3554 亿美元，预测期内（2025-2032 年）的复合年增长率为 10.3%。

福斯可林因其在提高环磷酸腺苷水平方面的作用而闻名，环磷酸腺苷可以调节新陈代谢和炎症，并且已成为一种流行的减肥补充剂和治疗气喘、湿疹和干癣的药物。它用于阿育吠陀医学和对抗疗法，但其有效性和安全性仍需进一步研究。随着健康意识的增强，全球对草药产品的需求不断增加，这反映了膳食补充剂、食品、饮料和化妆品的萃取物纯度水平范围不断扩大。在北美，尤其是美国，由于肥胖率上升和对天然替代品的偏好，福斯可林占据了市场占有率。在亚太地区，印度凭藉其在传统草药方面的根基占据市场领先地位。研究表明，福斯可林可能有助于改善身体组成和气喘，其市场影响有望成长。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管格局
• 案例研究
• 技术进步

福斯可林市场规模（依浓度及复合年增长率） （2025-2032）

• 市场概览
• 低浓度（10%）
• 中等浓度（20%-40%）
• 高浓度（95%）

福斯可林市场规模（依应用）及复合年增长率（2025-2032）

• 市场概览
• 过敏治疗
• 体重管理
• 呼吸问题
• 心血管疾病
• 青光眼
• 甲状腺机能低下症
• 干癣
• 其他的

福斯可林市场规模（依最终用户划分）及复合年增长率（2025-2032）

• 市场概览
• 营养补充品
• 製药
• 营养补充品
• 其他的

福斯可林市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Alchem International Ltd.（India）
• Nutra Green Biotechnology Co., Ltd.（China）
• Shaanxi Jiahe Phytochem Co., Ltd.（China）
• Glentham Life Sciences（United Kingdom）
• Flavour Trove（India）
• Cymbio Pharma Pvt. Ltd.（India）
• Alpspure Lifesciences Pvt. Ltd.（India）
• Bioprex Labs（India）
• Deccan Nutraceuticals Pvt. Ltd.（India）
• Ennature Biopharma（India）
• Sunpure Extracts Pvt. Ltd.（India）
• Sabinsa Corporation（United States）
• Indena SpA（Italy）
• ChromaDex Corp.（United States）
• Herbal Nutrition LLC（United States）
• Himalaya Wellness（India）
• Life Extension（United States）
• Nature's Way Products, LLC（United States）
• Swanson Health Products, Inc.（United States）
• NOW Foods（United States）

结论和建议

Forskolin Market size was valued at USD 511.3 million in 2023 and is poised to grow from USD 563.96 million in 2024 to USD 1235.54 million by 2032, growing at a CAGR of 10.3% during the forecast period (2025-2032).

Forskolin, known for its role in enhancing cyclic AMP levels-which regulates metabolism and inflammation-has gained traction as a weight loss supplement and treatment for asthma, eczema, and psoriasis. Despite the need for more research on its efficacy and safety, its use spans both Ayurvedic and allopathic medicine. Variations in extract purity cater to dietary supplements, food and beverages, and cosmetics, reflecting a growing global demand for herbal products as health concerns escalate. In North America, particularly the U.S., forskolin leads with over 90% market share, driven by rising obesity rates and the preference for natural alternatives. In the APAC region, India tops the market, supported by its traditional medicinal roots. As studies suggest forskolin's potential in improving body composition and aiding asthma, its market presence is poised for growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Forskolin market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Forskolin Market Segments Analysis

Global Forskolin Market is segmented by Concentration, Application, End-User and region. Based on Concentration, the market is segmented into Low Concentration (10%), Medium Concentration (20%-40%) and High Concentration (95%). Based on Application, the market is segmented into Allergy Treatment, Weight Management, Respiratory Problems, Cardiovascular Disorders, Glaucoma, Hypothyroidism, Psoriasis and Others. Based on End-User, the market is segmented into Nutraceuticals, Pharmaceuticals, Dietary Supplements and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Forskolin Market

A key factor propelling the Forskolin market is the surging demand for natural health supplements. Forskolin, extracted from the root of the Coleus forskohlii plant, has a long history in traditional medicine for treating various health issues. As consumers become more aware of the benefits associated with natural products and express growing concerns about the adverse effects of synthetic pharmaceuticals, the appeal of Forskolin supplements is on the rise. Additionally, the increasing incidence of chronic illnesses like obesity and cardiovascular diseases is further bolstering the market, as Forskolin is widely regarded as a safe and effective option for managing such health challenges.

Restraints in the Forskolin Market

A significant challenge facing the Forskolin market is the absence of regulation and standardization in the manufacturing and distribution processes of Forskolin products. As the demand for natural health supplements has surged, a wide array of Forskolin products has flooded the market, many of which may not adhere to established quality and safety standards. This situation poses a risk for consumers who might end up purchasing products that are not only ineffective but could also be detrimental to their health. Additionally, the lack of regulation leads to inconsistencies in the potency and purity of these products, resulting in varying therapeutic benefits, which undermines consumer trust and market stability.

Market Trends of the Forskolin Market

The forskolin market is experiencing a notable trend driven by a growing preference for natural and herbal remedies among health-conscious consumers. As more individuals seek alternatives to synthetic chemicals, forskolin-derived from the Coleus forskohlii plant-has gained traction for its potential health benefits, including weight management and metabolic improvement. This increasing awareness is further fueled by the rising prevalence of lifestyle-related conditions such as obesity and diabetes, prompting consumers to explore natural solutions. Additionally, the market is becoming increasingly competitive, with new entrants pushing innovation and the development of diverse, innovative forskolin products, thereby amplifying the market's growth trajectory.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global Forskolin Market Size by Concentration & CAGR (2025-2032)

• Market Overview
• Low Concentration (10%)
• Medium Concentration (20%-40%)
• High Concentration (95%)

Global Forskolin Market Size by Application & CAGR (2025-2032)

• Market Overview
• Allergy Treatment
• Weight Management
• Respiratory Problems
• Cardiovascular Disorders
• Glaucoma
• Hypothyroidism
• Psoriasis
• Others

Global Forskolin Market Size by End-User & CAGR (2025-2032)

• Market Overview
• Nutraceuticals
• Pharmaceuticals
• Dietary Supplements
• Others

Global Forskolin Market Size & CAGR (2025-2032)

• North America (Concentration, Application, End-User)
  • US
  • Canada
• Europe (Concentration, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Concentration, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Concentration, Application, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Concentration, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Alchem International Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nutra Green Biotechnology Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shaanxi Jiahe Phytochem Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Glentham Life Sciences (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Flavour Trove (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cymbio Pharma Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alpspure Lifesciences Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioprex Labs (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Deccan Nutraceuticals Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ennature Biopharma (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sunpure Extracts Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sabinsa Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Indena S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ChromaDex Corp. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Herbal Nutrition LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Himalaya Wellness (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Life Extension (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nature's Way Products, LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Swanson Health Products, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NOW Foods (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations